|
Commitments and Contingencies (Details Textual) (USD $)
|
3 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Jul. 31, 2012
Advisory Agreement
|
Jul. 31, 2012
Consulting Agreement
|
Jul. 31, 2012
Minimum
Advisory Agreement
|
Jul. 31, 2012
Maximum
Advisory Agreement
|
Apr. 01, 2012
Executive Chairman
|
Sep. 30, 2013
Executive Chairman
|
Jun. 30, 2013
Executive Chairman
|
Dec. 31, 2012
Executive Chairman
|
Jun. 18, 2012
Chief Executive Officer
|
Sep. 30, 2013
Chief Executive Officer
|
Jun. 30, 2013
Chief Executive Officer
|
Dec. 31, 2012
Chief Executive Officer
|
Sep. 30, 2013
Chief Scientific Officer
|
Dec. 31, 2012
Chief Scientific Officer
|
Jun. 30, 2013
Chief Scientific Officer
|
|
| Initial salary paid | $ 250,000 | $ 230,000 | $ 275,000 | ||||||||||||||
| Increase decrease in base salary | 325,000 | 325,000 | 350,000 | 295,000 | 295,000 | ||||||||||||
| Increase decrease in aggregate value of financing activities | 5,000,000 | ||||||||||||||||
| Percentage of annual performance bonus | 30.00% | 30.00% | 40.00% | 40.00% | 40.00% | 40.00% | |||||||||||
| Purchase of common stock shares percentage | 5.00% | 5.00% | |||||||||||||||
| Sharebased compensation arrangement by sharebased payment award options vested percentage | 50.00% | 50.00% | |||||||||||||||
| Bonus paid | 40,000 | 275,000 | 275,000 | ||||||||||||||
| Minimum value of financing activities | 5,000,000 | ||||||||||||||||
| Proceeds from issuance of stock option to purchase of common stock | 3,500,000 | ||||||||||||||||
| Services agreement expenses | $ 9,000 | $ 9,000 | $ 100 | $ 700 | |||||||||||||